iShares Biotechnology ETF (IBB) Holdings $131.67 -1.85 (-1.39%) (As of 05:46 PM ET) Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipSEC FilingsShort InterestTrends Top 50 IBB HoldingsRankCompanyCurrent PriceWeightShares Held1GILDGilead Sciences$92.01-2.2%8.65%02AMGNAmgen$259.30-1.3%7.90%03REGNRegeneron Pharmaceuticals$702.59-1.4%7.55%04VRTXVertex Pharmaceuticals$399.35-2.3%7.43%05IQVIQVIA$197.45-1.0%3.59%06ALNYAlnylam Pharmaceuticals$236.01-0.8%3.04%0 Get the Latest News and Ratings for IBB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 7ARGXargenx$619.96-1.0%2.93%08MTDMettler-Toledo International$1,219.92-1.2%2.56%09WATWaters$370.94-1.0%2.22%010BIIBBiogen$150.19-0.7%2.19%011BNTXBioNTech$112.58-1.2%2.13%012ILMNIllumina$133.57-1.3%2.13%013NTRANatera$158.55-1.1%1.99%014UTHRUnited Therapeutics$357.64-0.6%1.58%015MRNAModerna$39.38-1.9%1.38%016BGNEBeiGene$183.81+1.1%1.37%017NBIXNeurocrine Biosciences$137.06-1.7%1.37%018INCYIncyte$68.42-1.2%1.31%019BMRNBioMarin Pharmaceutical$65.45-2.2%1.26%020INSMInsmed$68.87-1.1%1.21%021TECHBio-Techne$72.29-0.9%1.15%022GMABGenmab A/S$20.77-1.2%1.09%023SRPTSarepta Therapeutics$121.19-0.3%1.08%024PCVXVaxcyte$81.99+1.3%0.97%025CRLCharles River Laboratories International$183.42-1.5%0.94%026EXELExelixis$33.70-0.3%0.94%027MEDPMedpace$333.34-2.3%0.87%028ITCIIntra-Cellular Therapies$83.48-1.6%0.84%029RGENRepligen$143.81-1.2%0.76%030ASNDAscendis Pharma A/S$136.48-0.7%0.65%031RVMDRevolution Medicines$43.17-2.4%0.62%032HALOHalozyme Therapeutics$47.99-0.3%0.61%033BRKRBruker$58.50+0.2%0.60%034MDGLMadrigal Pharmaceuticals$311.62-0.5%0.58%035BPMCBlueprint Medicines$86.82-2.9%0.55%036CYTKCytokinetics$47.15-0.4%0.54%037IONSIonis Pharmaceuticals$34.92-2.8%0.52%038ALKSAlkermes$28.78-2.6%0.47%039LEGNLegend Biotech$32.77+0.9%0.47%040CRNXCrinetics Pharmaceuticals$50.67-2.3%0.45%0⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>>41ROIVRoivant Sciences$11.43-3.1%0.45%042BBIOBridgeBio Pharma$27.32-2.4%0.41%043ADMAADMA Biologics$17.49+0.2%0.40%044KRYSKrystal Biotech$159.80+0.3%0.39%045RAREUltragenyx Pharmaceutical$42.27-2.6%0.36%046AXSMAxsome Therapeutics$84.78-2.2%0.34%047PTCTPTC Therapeutics$45.77+1.2%0.34%048APLSApellis Pharmaceuticals$31.90-2.4%0.33%049RNAAvidity Biosciences$29.18-3.1%0.33%050NUVLNuvalent$77.87-3.0%0.33%0 Geographic ExposureUnited States96.3%Ireland0.5%Canada0.5%Bermuda0.4%Netherlands0.4%Switzerland0.3%Virgin Islands, British0.3%Jersey0.3%Singapore0.2%Luxembourg0.1%Italy0.1%Cayman Islands0.1%Currency ExposureUSD100.0%Sector ExposureHealth Care84.1%Consumer Discretionary0.4%Industrials0.1%Industry ExposureBiotechnology66.7%Health Care Equipment & Supplies9.8%Health Care Providers & Services6.5%Diversified Consumer Services0.9%Distributors0.3%Pharmaceuticals0.2%Commercial Services & Supplies0.1%SubIndustry ExposureBiotechnology62.8%Life Sciences Tools & Services10.4%Health Care Services6.5%Pharmaceuticals0.8%Health Care Equipment0.4%Coupon Exposure0-299.8%4-60.2% Related Companies and Tools Related Companies PPH Holdings BBH Holdings PSCH Holdings PTH Holdings BIB Holdings LFSC Holdings IBBQ Holdings MEDX Holdings FTXH Holdings JDOC Holdings This page (NASDAQ:IBB) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
